REMS Standardization and Evaluation Public Meeting: July 25-26, 2013
Silver Spring, MD
San Francisco, California
London, United Kingdom
Note to speakers: If you are using slides, copies of your final slides should be submitted as soon as possible.
Webcast viewers and attendees who do not wish to speak can continue to register through July 24th.
The Food and Drug Administration (FDA) is holding a 2-day public meeting on July 25 and 26, 2013 to obtain input on issues and challenges associated with the standardization and assessment of risk evaluation and mitigation strategies (REMS) for drugs. More information on this meeting is available here.
This meeting is being coordinated by FDA's REMS Integration Initiative. For more information, please visit the initiative's website.
We encourage attendees to provide written comments to the public docket for the meeting. The docket will remain open indefinitely. However, comments should be submitted no later than September 16th if you would like them to be considered for FDA's report of its findings on standardization and identification of priority projects.